| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Whitehawk Therapeutics, Inc.
13D/A
WHWK · 00032Q104
|
9.0% |
5/18/2026
Event 5/14/2026
|
||||
| Acuta Capital Partners, LLC | 8.7% | |||||
| Anupam Dalal | 9.0% | |||||
| Acuta Capital Fund, LP | 6.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.